StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Ajit Mishra, Religare

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byAjit Mishra, ReligareHorizon: NA (inferred Swing (≤2wk))29 Jul 2026via ET Now

Entry₹1,993.1Inferred
Target₹2,100
Total upside +5.36% (call closed)
Stop loss₹1,920-3.67% risk
At expiry₹1,94412 Aug 2026, 3:30 pm
Expired-2.46%auction close
Follow Ajit Mishra for new calls(22% target hit, 114 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 12 Aug 2026
3 supporting2 neutral1 opposing
Supports the BUY call (3)

Sun Pharma has received approval to manufacture and market semaglutide in Brazil, indicating a potential market expansion and new product offering.

BSE · Company Update·29 Jul · 2w ago

(opens in new tab)

3 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·30 Jul · 2w ago

Sun Pharma announced that Organon shareholders have approved the proposed acquisition, moving forward the company's strategic expansion plans.

BSE · Company Update·24 Jul · 3w ago

(opens in new tab)
Neutral / worth noting (2)

CRISIL has removed the 'Rating Watch with Developing Implications' status and reaffirmed Sun Pharma's long-term bank facilities rating at 'CRISIL AAA/Stable'.

BSE · Company Update·5 Aug · 1w ago

(opens in new tab)

Unaudited Standalone and Consolidated Financial Results for Q1 of FY 2026-27

NSE · Outcome of Board Meeting·31 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Pharma stocks: Sun Pharma, Biocon, Dr Reddy's, Torrent Pharma slip on Trump's generic drug tariff plan

NewsGoogle News·23 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Ajit Mishra, Religare

Every call and its outcome